Inhibitors targeting hnRNP A0 belong to a class of chemical compounds designed to selectively modulate the activity of the heterogeneous nuclear ribonucleoprotein A0 (hnRNP A0) protein. hnRNP A0 is a member of the hnRNP family, a group of RNA-binding proteins that play critical roles in the processing, transport, and regulation of pre-mRNA within the nucleus. These proteins are essential for the splicing of pre-mRNA into mature mRNA, and hnRNP A0, in particular, is involved in the formation of the spliceosome complex, which is responsible for accurately excising introns and joining exons during mRNA maturation. This process is vital for gene expression regulation and ensuring the production of functional proteins.
Inhibiting hnRNP A0 can be instrumental in studying the intricacies of pre-mRNA splicing and its regulatory mechanisms. Researchers use these inhibitors to dissect the role of hnRNP A0 in spliceosome assembly and function, as well as its interactions with other RNA-binding proteins and spliceosomal components. By manipulating hnRNP A0 activity, scientists gain insights into the molecular basis of alternative splicing, a phenomenon that generates multiple protein isoforms from a single gene and plays a significant role in cellular diversity and disease. Moreover, understanding hnRNP A0 inhibition can provide a better understanding of the broader hnRNP family's functions, offering potential avenues for research and insights into genetic diseases resulting from splicing abnormalities.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Antibiotic that can inhibit RNA polymerase in prokaryotes and, to a lesser extent, in eukaryotes, potentially affecting hnRNP A0 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Inhibits DNA topoisomerase I, leading to DNA damage and potentially altering hnRNP A0 expression indirectly. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $142.00 $558.00 | 4 | |
Intercalates with DNA and inhibits DNA topoisomerase II, which might influence hnRNP A0 mRNA synthesis. | ||||||
Harringtonin | 26833-85-2 | sc-204771 sc-204771A sc-204771B sc-204771C sc-204771D | 5 mg 10 mg 25 mg 50 mg 100 mg | $195.00 $350.00 $475.00 $600.00 $899.00 | 30 | |
Inhibits protein synthesis at the level of translation elongation, which could indirectly decrease hnRNP A0 levels. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Causes premature termination of mRNA translation, potentially leading to reduced hnRNP A0 protein synthesis. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Cross-links DNA upon reductive activation, which could disrupt transcription and reduce hnRNP A0 expression. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $82.00 $300.00 $1082.00 | 30 | |
Inhibits DNA polymerase and may indirectly reduce hnRNP A0 expression by causing a reduction in overall mRNA synthesis. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Inhibits peptide bond formation by binding to the 60S ribosomal subunit, potentially decreasing hnRNP A0 protein levels. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Terminates mRNA synthesis prematurely by acting as an adenosine analog, potentially decreasing hnRNP A0 mRNA levels. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
A plant alkaloid shown to have DNA intercalating properties, possibly altering transcription and affecting hnRNP A0 expression. | ||||||